Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Weekend Drug Holiday of Dasatinib in CML Patients Not Tolerating Standard Dosing Regimens. Reducing Toxicity with Maintained Disease Control.

Paul La Rosee, MD, Armin Leitner, MD, Philippe Martiat, MD, Thomas Klag, MD, Samina Shazi, MD, Anne Treschl, MD, Martin C Müller, MD, Thomas Schenk, MD, Benjamin Hanfstein, Andreas Hochhaus, MD

Blood (2009) 114 (22): 1119.

https://doi.org/10.1182/blood.V114.22.1119.1119

Published: 2009

Journal Articles

The Role of GM-CSF in Haplo-Identical Transplant Patients Who Do Not Benefit from NK Alloreactivity.

Philippe Lewalle, MD, Alain Delforge, PhD, Berengere Nowak, BSc, Virginie Misplon, BSc, Jalil Bennani, MD, PhD, Dominique Bron, MD, PhD, Philippe Martiat, MD, PhD

Blood (2005) 106 (11): 2912.

https://doi.org/10.1182/blood.V106.11.2912.2912

Published: 2005

Journal Articles

Immunological Recovery after Nonmyeloablative Transplant: A Prospective Study of 24 Patients Treated in a Single Center.

Dominique Bron, MD PhD, Van Hyunh, MD, Virginie Dewilde, MD, Jalil Bennani, MD, Philippe Lewalle, MD, Phuong Huynh, MD, Rita Leroy, Patrick Crombez, Louisette Debusscher, MD, Walter Feremans, MD, PhD, Michel Bernier, MD, Philippe Martiat, MD

Blood (2004) 104 (11): 5044.

https://doi.org/10.1182/blood.V104.11.5044.5044

Published: 2004

Journal Articles

Fludarabine Phosphate-Based Nonmyeloablative Stem Cell Transplantation in the Elderly Patients: A BHS Study.

Dominique Bron, MD, PhD, Pierre Zachée, MD, Johan Maertens, MD, Koen Theunissen, MD, Augustin Ferrant, MD, PhD, Philippe Martiat, MD, PhD, Chantal Doyen, MD, Luc Noens, MD, Wilfried Schroyens, MD, Dominique Sellesslag, MD, Hilde Demuynck, MD, Rick Schots, MD, PhD, Anne De Meuter, Marc Boogaerts, MD, PhD

Blood (2004) 104 (11): 5046.

https://doi.org/10.1182/blood.V104.11.5046.5046

Published: 2004

Journal Articles

Can Addition of GM-CSF in Adult Haplo-Identical Transplant Who Cannot Benefit from NK Alloreactivity Improve the Relapse Rate of Advanced Leukemia: A 3 Step Study.

Philippe Lewalle, MD, Alain Delforge, PhD, Berengere Nowak, BS, Virginie Misplon, Laurence Lagneaux, PhD, Koen Theunissen, MD, PhD, Jalil Bennani, MD, Dominique Bron, MD, PhD, Philippe Martiat, MD, PhD

Blood (2004) 104 (11): 4975.

https://doi.org/10.1182/blood.V104.11.4975.4975

Published: 2004

NARROW

Weekend Drug Holiday of Dasatinib in CML Patients Not Tolerating Standard Dosing Regimens. Reducing Toxicity with Maintained Disease Control.

The Role of GM-CSF in Haplo-Identical Transplant Patients Who Do Not Benefit from NK Alloreactivity.

Immunological Recovery after Nonmyeloablative Transplant: A Prospective Study of 24 Patients Treated in a Single Center.

Fludarabine Phosphate-Based Nonmyeloablative Stem Cell Transplantation in the Elderly Patients: A BHS Study.

Can Addition of GM-CSF in Adult Haplo-Identical Transplant Who Cannot Benefit from NK Alloreactivity Improve the Relapse Rate of Advanced Leukemia: A 3 Step Study.

Email alerts

ASH Publications

American Society of Hematology

Weekend Drug Holiday of Dasatinib in CML Patients Not Tolerating Standard Dosing Regimens. Reducing Toxicity with Maintained Disease Control.

The Role of GM-CSF in Haplo-Identical Transplant Patients Who Do Not Benefit from NK Alloreactivity.

Immunological Recovery after Nonmyeloablative Transplant: A Prospective Study of 24 Patients Treated in a Single Center.

Fludarabine Phosphate-Based Nonmyeloablative Stem Cell Transplantation in the Elderly Patients: A BHS Study.

Can Addition of GM-CSF in Adult Haplo-Identical Transplant Who Cannot Benefit from NK Alloreactivity Improve the Relapse Rate of Advanced Leukemia: A 3 Step Study.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only